financetom
Business
financetom
/
Business
/
Trinity Capital Originates $774 Million in Q3 Commitments
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Trinity Capital Originates $774 Million in Q3 Commitments
Oct 9, 2025 6:19 AM

08:46 AM EDT, 10/09/2025 (MT Newswires) -- Trinity Capital ( TRIN ) said Thursday that it originated $773 million of new commitments in Q3.

Investments funded during Q3 totaled $471 million.

Trinity said it funded $272 million to 17 new portfolio companies and $176 million to 20 existing portfolio companies.

The company said proceeds received from repayments and exits from its investments totaled $255 million, which included $56 million from early debt repayments, $79 million from scheduled/amortizing debt payments, and $120 million from investments sold primarily to multi-sector holdings.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
AbbVie forecasts 2025 profit above estimates, driven by newer immunology drugs
AbbVie forecasts 2025 profit above estimates, driven by newer immunology drugs
Jan 31, 2025
* Skyrizi, Rinvoq sales expected to surpass $31 billion by 2027 * Humira sales decline 49% due to cheaper biosimilar competitors * AbbVie ( ABBV ) earns $2.16 per share in Q4, beats estimates Jan 31 (Reuters) - AbbVie ( ABBV ) forecast 2025 profit above estimates on Friday, as strong sales of its newer immunology drugs Skyrizi and Rinvoq...
Vestis Fiscal Q1 Adjusted Earnings, Revenue Fall; Fiscal 2025 Sales Outlook Reiterated
Vestis Fiscal Q1 Adjusted Earnings, Revenue Fall; Fiscal 2025 Sales Outlook Reiterated
Jan 31, 2025
07:32 AM EST, 01/31/2025 (MT Newswires) -- Vestis ( VSTS ) reported fiscal Q1 adjusted earnings Friday of $0.14 per share, down from $0.22 a year earlier. An analyst polled by FactSet expected $0.13. Revenue for the quarter ended Dec. 27 was $683.8 million, compared with $717.9 million a year earlier. Analysts surveyed by FactSet expected $688.9 million. The company...
WisdomTree Q4 Adjusted Earnings, Operating Revenue Rise
WisdomTree Q4 Adjusted Earnings, Operating Revenue Rise
Jan 31, 2025
07:36 AM EST, 01/31/2025 (MT Newswires) -- WisdomTree ( WT ) reported Q4 adjusted earnings Friday of $0.17 per diluted share, up from $0.11 a year earlier. Analysts polled by FactSet expected $0.18. Operating revenue for the quarter ended Dec. 31 was $110.7 million, compared with $90.8 million a year earlier. Analysts surveyed by FactSet expected $110.7 million. ...
GSK's ViiV Healthcare Secures EU Approval for Vocabria Combination Therapy for HIV Treatment in Adolescents
GSK's ViiV Healthcare Secures EU Approval for Vocabria Combination Therapy for HIV Treatment in Adolescents
Jan 31, 2025
07:32 AM EST, 01/31/2025 (MT Newswires) -- GSK (GSK) said Friday that its majority owned ViiV Healthcare unit has received European Commission approval for Vocabria, in combination with Johnson & Johnson's ( JNJ ) Rekambys, for the treatment of HIV-1 infection in adolescents 12 years of age and older weighing at least 35 kilograms. The marketing authorizations are backed by...
Copyright 2023-2026 - www.financetom.com All Rights Reserved